BNP Paribas Financial Markets’s Ocugen OCGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$455K Buy
297,285
+286,262
+2,597% +$435K ﹤0.01% 3817
2026
Q1
$20K Sell
11,023
-5,384
-33% -$9.31K ﹤0.01% 5091
2025
Q4
$22.1K Buy
16,407
+11,998
+272% +$17.1K ﹤0.01% 4993
2025
Q3
$7.19K Sell
4,409
-32,413
-88% -$35.9K ﹤0.01% 5057
2025
Q2
$35.7K Buy
36,822
+13,326
+57% +$11.1K ﹤0.01% 4376
2025
Q1
$16.6K Sell
23,496
-13,363
-36% -$9.24K ﹤0.01% 4588
2024
Q4
$29.7K Buy
+36,859
New +$33.7K ﹤0.01% 4609
2022
Q4
Sell
-584,292
Closed -$1.04M 4426
2022
Q3
$1.04M Buy
+584,292
New +$1.45M ﹤0.01% 2457

Other funds holding OCGN

BNP Paribas Financial Markets's OCGN Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its Ocugen (OCGN) stake by 2,597% in Q2 2026, buying an estimated $435K and bringing the position to 297,285 shares worth $455K. The position accounts for ﹤0.01% of the portfolio, ranked #3817.

BNP Paribas Financial Markets first reported a position in OCGN in Q3 2022 and has held it in 8 quarters since. The position peaked at $1.04M in Q3 2022. 141 funds tracked by Wall St. Rank hold OCGN as of Q2 2026.

  • BNP Paribas Financial Markets held 297,285 shares of Ocugen worth $455K as of Q2 2026.
  • BNP Paribas Financial Markets bought 286,262 Ocugen shares in Q2 2026, an estimated $435K.
  • Ocugen made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #3817 holding.
  • BNP Paribas Financial Markets first reported a position in Ocugen in Q3 2022 and has held it in 8 quarters since.
  • BNP Paribas Financial Markets's Ocugen position peaked at $1.04M in Q3 2022.
  • 141 funds tracked by Wall St. Rank held Ocugen as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.